Showing results (741-750 of 4,634) with videos related to
Sort By:
Pageof 464
Anti-Cancer Drugs|March 27, 2002
Efficient induction of apoptosis by ONYX-015 adenovirus in human colon cancer cell lines regardless of p53 statusT Petit, K K Davidson, C Cerna, et al.Anti-Cancer Drugs|April 1, 1995
A randomized trial of two schedules of trimetrexate versus 5-fluorouracil in advanced colorectal cancer: a Southwest Oncology Group studyT D Brown, T R Fleming, P J Goodman, et al.Anti-Cancer Drugs|April 1, 1995
Cost effectiveness of 5-hydroxytryptamine3 receptor antagonists: a retrospective comparison of ondansetron and granisetronN Johnson, N BosanquetAnti-Cancer Drugs|April 1, 1995
In vitro assessment of Taxol for human glioblastoma: chemosensitivity and cellular locomotionD L Silbergeld, M R Chicoine, C L MadsenAnti-Cancer Drugs|April 1, 1995
Schedule-dependent enhancement of antitumor activity of ethyldeshydroxy-sparsomycin in combination with classical antineoplastic agentsH P Hofs, D J Wagener, V de Valk-Bakker, et al.Anti-Cancer Drugs|June 1, 1993
Differential reversal of lipophilic antifolate resistance in mammalian cells with modulators of the multidrug resistance phenotypeY G Assaraf, M J BorgniaAnti-Cancer Drugs|August 1, 1993
A saturation threshold for taxol cytotoxicity in human glial and neuroblastoma cellsL Helson, C Helson, S Malik, et al.Anti-Cancer Drugs|December 1, 1994
P-glycoprotein overexpression in mouse cells does not correlate with resistance to N-benzyladriamycin-14-valerate (AD 198)L Lothstein, Y Koseki, T W SweatmanAnti-Cancer Drugs|December 1, 1994
Topoisomerase I gene expression and cell sensitivity to camptothecin in human cell lines of different tumor typesP Perego, G Capranico, R Supino, et al.Anti-Cancer Drugs|August 1, 1994
Ifosfamide induced depletion of glutathione in human peripheral blood lymphocytes and protection by mesnaT Meier, A Allenbacher, E Mueller, et al.Pageof 464